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Introduction
Tuberculosis (TB) is a world-wide [1] problem and it is estimated that one-third of the world's population is infected with the Mycobacterium tuberculosis [2] . It is also the leading cause of death due to a single infectious disease [3] . TB is an airborne disease and can be transmitted from one person to another by cough, sneeze, speak etc. [4, 5] .
Many mathematical models have been created to describe the dynamics of this illness and many others [6, 7] . Most of these models deal with the problem of transmission dynamics with emergence of drug resistance [8] [9] [10] [11] [12] [13] [14] [15] , impact of other infections on TB [16, 17] and the role of dormancy in the persistence of the infection [18] . In contrast, within-host models have received little attention [15, [18] [19] [20] [21] .
Within-host models have several advantages for study the evolution and spread of a disease [22] [23] [24] [25] [26] . One of these advantages is that the host's health state is defined according to his/her internal population of pathogens. In transmission models, transitions among states are fixed parameters determined only by external factors. In contrast, in within-host models, transitions 2 among host's health states emerge naturally from changes in the host's pathogen populations.
The possibility of defining a different set of parameters for each host is another important feature of these kinds of models. Immune response, initial load of pathogens, bacterial rate of dormancy and others parameters allow the creation of heterogeneous populations [18, [27] [28] [29] [30] [31] . Within-host heterogeneity parameters (governed by the individual's biological characteristics) are useful to study TB spread because it is possible to simulate a large spectrum of virtual populations.
In principle, models of disease transmission from one individual to another can also be augmented by combining them with withinhost models. Contagion no longer occurs because of some fixed probability, but it also depends on the amount of pathogens involved in the process. Thus, the transmission of the disease among individuals on a population can be informed by monitoring host parameters.
In previous models, resistant strains [15] and bacterial dormancy [18] are treated separately. We propose to combine both effects simultaneously in a within-host model. Further, in our model, there is 3 an interplay among sensitive/resistant pathogens, immune system cells, bacterial dormancy and antibiotics as the key features of the dynamics. Additionally, the immune system is assumed to depend on T-cell migration from the thymus, with a limited reproduction cycle.
The emergence of drug resistance due to the use of antibiotics [32] [33] [34] is analyzed using three different treatment protocols. The This paper is organized as follows. In Section The Model, we describe the methods to build the within-host model of TB describing variables and parameters of the system. Also the dynamics of the within-host model is explained in details using coupled ordinary differential equations. Model numerical solutions and results are discussed in Sec. Results. In this section we present the way 4 outcomes of the within-host dynamics are related to the host health states. Concluding remarks and our perspective on future studies are discussed in the last section.
The Model
Based on the models from Refs. [15, 18] , we propose a within-host model of Tuberculosis. We consider two types of M. tuberculosis strains: sensitive type, S, which can be killed by treatment with antibiotics; and a resistant type, R, which is resistant to the treatment. The influence of bacterial dormancy in the disease prevalence is also considered including dormant sensitive and dormant resistant types of bacteria, S d and R d , respectively. We also model the emergence of drug resistance due the treatment with antibiotics.
The dynamics of bacterial populations and the immune system are modeled by using differential equations. The within-host system, defined by these set of equations, is solved numerically. We note that outcomes presented in the following sections are for one host only; the process of contagion or any interaction among hosts are not considered in this work. 5 As mentioned above, the host health states are a consequence of the within-host dynamics. These states indicate the stage of the disease in which a host may be. In the case of TB, we define the possible health states for a host as: X, susceptible, L i , latent; or T i , infectious. The subscript i = S, R defines the type of pathogen:
sensitive or resistant to antibiotics, respectively. Susceptible individuals, X, are those that had no contact with TB pathogens. They are healthy and their system is free of tuberculosis pathogens. Individuals previously susceptible who acquire TB pathogens may enter into a latency period. A latent state, L i , is the stage when there are no disease symptoms. Finally, individuals in the infectious state, T i , are in the active tuberculosis stage, i.e., the host is sick. Antibiotic treatment is applied in this stage of the disease.
M. Tuberculosis may enter mononuclear cells like the immune system cells, the T-cells [18] . A fraction of these bacteria go into a dormancy state for some time and consequently they do not reproduce [35] . During the dormancy state these pathogens are not detected by the immune system and they also can not be affected by the antibiotics [18, 36, 37] . Dormant sensitive and resistant bacteria will be represented as S d and R d , respectively. 6 On one hand, population of active sensitive pathogens, S, reproduce at rate (1−q)ν and they also may be converted to a dormant state, S to S d , at a rate f . On the other hand, the conversion back from the dormant to the active state, S d to S, occurs at a rate g. The S type pathogens can be killed by the immune system response, I, or by the action of antibiotics with a clearance rate α. The two types of strains compete for resources, thus a competition term [15] ν(S + R)S/k b is added to the dynamics. This competition is only by their intrinsic growth rate and efficiency in utilizing available nutrients [38] . Then, as modeled in Ref. [15] , a logistic competition term mimics the competition of survival between S and R pathogens.
Due to mutations, type S pathogens may give rise to active resistant type bacteria, R, at rate qν. Reproduction of R population that already exist occurs at rate ν 1 , which is lower than type S because of an evolutionary cost [39] . Conversion from active state to a dormant state, R to R d is also possible, as well as the conversion back to activity. Rates of conversion from active to dormant and dormant to active states are f and g, respectively, as for sensitive pathogen.
Because of resistance to antibiotics, drug efficacy to clear R type 7 bacteria is reduced by a factor δ. Consequently, the clearance rate due the use of antibiotics is lower than the one obtained to treat S type infections. Resistant strains can be killed by the immune system similarly as the type S pathogens. Analogously to S strains, resistant bacteria has a competition term added to their dynamics, ων(S + R)R/k b .
The within-host system evolves according to the equations:
Definition of the parameters used in Eqs.
(1-4) as well as their respective ranges are in Table 1 .
The last terms in Eqs. (1) and (3) are the competition terms between S and R strains. The amount of pathogens, Ω = S +R, is the bacterial load inside the host's lung which determines his/her health condition. Mutations have a fitness cost [39] that may affect the reproduction ability of these strains [40] .
The immune system, I, is modeled similarly to the dynamics pre-8 sented in Ref. [18] . Firstly, consider the thymus, an organ where immature T-cells stay until they fully mature [41, 42] . Let a(Ω)
be the immigration rate of T-cells from thymus, which depends on the pathogen density, given by:
where a 1 is the recruitment rate of T-cells from thymus; a 2 , pathogen load at which the immigration rate a(Ω) is half of the T-cell recruitment rate; and m defines the shape of recruitment function.
Note that as Antia et al [18] point out, "if the parasite persists, the presence of parasite antigens could lead to clonal deletion of parasite-specific immune cells in the thymus." In other words, the clonal deletion, or clonal elimination, is the elimination of T-cells that react with self antigens [42] . Thus, this phenomenon [41, 42] explains the negative sign in the second term of Eq. (5).
Moreover, the number of times that immune cells can reproduce is limited [43] . This is a phenomenon observed in epithelial cells by Hayflick and Moorhead [44] . The average number of times that a cell can reproduce is called the "Hayflick limit" [18] and for T-cells, reproduction can be repeated only about 23 times. 9 To incorporate the Hayflick limit in the model, a set of n equations represents the reproductive state of the T-cells [18] . The variable i j represents the population of T-cells in the j-th stage of the reproduction. Thus, the reproduction cycle of the immune cells is given by:
where, ǫ is the reproductive stimulus of T-cells; κ is a control density to make T-cells to reproduce up to half the maximum value and µ is the death rate of immune system cells. Thus, in each time step the total population of the immune system cells is
At each time step Eqs. (6) and (7) are concurrently solved and the immune system population is obtained by the sum defined in
For the sake of clarity, parameters of the model and their definition can be seen in Table 1 . In our model, cases of co-infection are not considered, in the sense that only one strain defines the type of infection, S or R.
As an example, one can see the bacterial load as function of time in Figure 4 (a). In the first 20 years prior to treatment, S population is higher than R population. Then, even though both strains coexist, we consider the host as being in T S state. Yet, in the 22th year, R population turns to be higher than S population.
Again, even both strains are present in the within-host, he/she is considered as T R . The same criteria is used to define whether the host is L S or L R . reproduction. Close to the end of the tenth year, the host system is completely clear of the infection. Note that no antibiotics was used in this case, α = 0. Once the host immune system has controlled the infection, but not cleared it, and Ω < Ω min , the latent stage starts. sensitive pathogens are completely cleared from the system. Because of the relative efficacy of antibiotics, δ = 0.5, the R population also decreases rapidly. Nevertheless, resistant strains are not completely cleared from this system. These two phenomena are followed by the increase in the immune system population, I. Fig. 4 , as soon the treatment ends, the immune system response is not enough to inhibit the R strain's growth. As long as the remaining resistant pathogens do not have to compete with sensitive strains (S = 0), their growth is faster. Thus, around the first month of the 21th year, this host becomes T R . This is a typical case of emergence of drug resistance due to the use of antibiotics. and thus they also are not affected by antibiotics. Thus, in the next subsection, the impact of this state in the outcome of the within-host system is tested by using a set of antibiotic protocols.
Also in

Protocols
In this section, the use of antibiotics is analyzed by testing differ- However, to check the evolution of the system with no medical intervention, we initially present a diagram without treatment. Note that for latent and active states, only sensitive pathogens are present. This is the reason that if no antibiotics is used, the 22 possibility for the R type to arise is due only to mutation of S during strain reproduction. 
Standard Protocol (SP)
The standard protocol (SP) is characterized by the fact that individuals are getting antibiotics on a daily basis during 180 days (6 months). 0.25, the immune system is strong enough to eliminate all type of pathogens (no active cases) or to allow the latency state (yellow area).
Intermittent Protocol (IP)
The intermittent protocol (IP) is characterized by the application of drugs in an intermittent fashion. More specifically, individuals get antibiotics during y days. These doses are interrupted for another n days. This cycle is repeated during a predetermined period, p. The relation y/n/p defines the type of intermittent protocols that is being implemented. (Fig. 9a) , a similar outcome with δ = 0.8 (Fig. 9b) and better than SP with δ = 0.0 (Fig. 8b) . This protocol has a smaller area for T S cases in comparison to the IP:3/6/540. Nevertheless, in the diagram of Fig. 9b , T R region is larger than in the Fig. 9a .
Oscillating Intermittent Protocol (OIP)
The oscillating intermittent protocol (OIP) is similar to intermittent protocol discussed previously. As mentioned before, α is the rate at which antibiotics kill S type bacteria. The main feature of OIP is that the value of α oscillates during the treatment. Thus, this parameter becomes time dependent and obeys the relation α t = ρα t−1 , where ρ is the drug dose reduction factor. For instance, OIP:3/6/540 means that the drug is: taken during three days (α is constant)/suspended by six days (α decays)/the whole treatment lasts 540 days.
Using OIP, we aim to simulate two different types of conditions.
Firstly, a scenario where the drug is not completely cleared from the host system in a period of one day. Thus we can observe how different amounts of the antibiotics, inside the host, can affect the 27 disease. Secondly, a kind of antibiotic which is taken up by the host during a period with different concentration. By concentration, we mean that each dose could be made of pills of different sizes. Fig. 10 . Oscillation of α t as function of time for intermittent protocols. At the first day of treatment, t = 0, α t=0 = 0.8 and it is reduced daily by a factor ρ = 0.8. Note that after a period of 9 days the parameter α t returns to its initial value α t=0 .
In Figure 10 , the behavior of α t as function of time in days, with a reduction factor, ρ = 0.8, is shown. In other words, α t is reduced 80% in relation to the value of the previous day. This daily reduction occurs in a period without treatment and then it returns to its initial value again. Again, the amount of doses taken is the same as in the standard 28 protocol.
The α t oscillation is implemented similarly to method shown in figure 10 . In the first day, α t=0 = 0.8 and then, in the second day, it is reduced for a value of α t=1 = ρα t=0 = 0.64, with ρ = 0.8.
In the third day, the antibiotics is again reduced for the value α t=2 = ρα t=1 = 0.512. Finally, the treatment is interrupted (α = 0) during 6 days and this whole cycle is repeated for 540 days.
The largest area in diagram of In order to understand why the OIP is so efficient, we present in Fig. 12 , how the population of S is changed for both protocols:
IP and OIP. It is clear that the population decreases in a faster rate for the OIP than IP. 
Discussion
In this paper we propose a within-host TB model with the interplay among sensitive/resistant pathogens, immune system cells, bacterial dormancy and antibiotics. In contrast to existing withinhost models, here resistant strains and bacterial dormancy are combined simultaneously in our model. The host's health state is defined according to his/her pathogen load, allowing more precise quantification of the distance between TB latency and activity. This is important to determine the necessity of an antibiotic treatment as well as its urgency.
A set of coupled ordinary differential equations describes the 
